large B-cell lymphoma (LBCL)axicabtagene ciloleucelchimeric antigen receptor T-cell therapyCARTPGS Catalog
…rmline genetic aberrations can affect outcomes in patients with large B-cell lymphoma (LBCL) treated with chimeric antigen receptor T-cell therapy (CART). H…